What's new

CDC data show 74% of people who tested positive for the virus in Massachusetts outbreak were fully vaccinated

yup. but unless I'm mistaken, almost all of 'em do recover due to having been vaccinated albeit they get critically sick to the extent that they have to hospitalized.
 
Look at the statistic from Singapore I provided above.

View attachment 767084

Around 5% of unvaccinated requires oxygen supplementation/ICU, while for fully vaccinated the figure is around 0.1%. Which means to say you're more than 10x likely to end up in serious condition if you're completely unvaccinated compared to fully vaccinated.

Thus, the claim of "80-90% protection against symptomatic disease or death" is reasonable.
"Mild Symptoms" is pretty misleading. People will see this chart and think mild symptoms are like a cold. In fact it's much more serious and you will likely be out for weeks. Mild symptoms here only means you aren't hospitalized.
 
American state propaganda mouthpieces and keyboard warriors got pretty silent about their "leaky vaccine" buzzword from last months fads to slander Chinese vaccines, abusing the vaccines real world records in affected primarily developing countries where vaccination and quarantines where slow and less well regulated due to infrastructural circumstances, opposed to ideal and handpicked lab tests and controlled and perfectly isolated areas in developed countries that dont rely on Chinas vaccine exports because they are hording their vaccinces for themself.

Suddenly its all about preventing death and hospitalization again like Sinovac did in once collapsing declared Chile where deaths have been steadily dropping for a month and infections tanking hard with inocculation rates nearing 100% and the situation normalizing so far they even lifted some quarantines, as opposed to the UK where deaths are accelerating upwards again along with infections bouncing up, no matter how much paid American shills lie into your face and try to assert the opposite, brazenly dressing up their lies with fancy datasheets clearly pointing into another direction if you actually read them.

Lol. If you have the guts, tag and quote my post instead.

Suddenly its all about preventing death and hospitalization again like Sinovac did

The ideal vaccine is still to prevent infections, not just deaths, so as to achieve herd immunity. Unfortunately, circumstances have changed for the worse. But even still, vaccines still have different efficacies and we're looking out for vaccines which can reduce mortality to the greatest extent even without preventing infection.

Because no current vaccine is effective in preventing delta infection, we have to fall back on looking at just mortality rates to determine which current vaccine can 'reduce mortality to the greatest extent'.

Also, delta is not the only variant around. Delta has not even hit Chile yet.

1628078655430.png


Chile where deaths have been steadily dropping for a month and infections tanking hard with inocculation rates nearing 100% and the situation normalizing so far they even lifted some quarantines, as opposed to the UK where deaths are accelerating upwards again along with infections bouncing up

You're selectively picking data, and you know that. What about the months before that?

Chile may have seen daily deaths fall in the past month, but it has not seen any significant reduction in deaths since inoculation started in January.

1628078147826.png

1628078164656.png


On the other hand, the UK has seen a significant reduction in deaths since its peak in January, despite the current uptick.

1628078015835.png

1628078029758.png


Chile's own real world study shows that there are indeed differences in vaccine efficacies.



SANTIAGO, Aug 3 (Reuters) - Sinovac's COVID-19 vaccine was 58.5% effective in preventing symptomatic illness among millions of Chileans who received it between February and July, the Chilean health authorities said on Tuesday, while Pfizer's COVID-19 shot was 87.7% effective and AstraZeneca's was 68.7% effective.

The data came in the latest "real world" data published by the Chilean authorities into the effectiveness among its population of a raft of COVID-19 vaccines.

Chile began one of the world's fastest inoculation campaigns against COVID-19 in December, having now fully vaccinated more than 60% of its population, predominantly with Sinovac's (SVA.O)CoronaVac.

That vaccine was 86% effective in preventing hospitalization, 89.7% effective in preventing admission to intensive care units and 86% effective in preventing deaths within the population between February and July, health official Dr Rafael Araos said in a press conference on Tuesday.

In April, the same study found that CoronaVac was 67% effective in preventing symptomatic illness, 85% effective in preventing hospitalizations and 80% effective in preventing deaths, suggesting its capacity to prevent the more serious impacts of the virus has strengthened, while its capacity to stop symptomatic illness diminished.

Araos said a reduction in protection from vaccines was inevitable over time, particularly with the arrival and growing prevalence of more virulent strains such as the Delta variant.

"If Delta becomes more prevalent and the vaccine has a weaker response, we could observe a faster fall (in effectiveness)," he said, adding his voice to calls for a third, booster dose to be issued.

The government also published data on the effectiveness of other vaccines administered in Chile, made by Pfizer BioNTech (PFE.N), (22UAy.DE) and AstraZeneca (AZN.L).

Pfizer's vaccine was 87.7% effective in preventing symptomatic COVID-19 in the same period, 98% effective in preventing intensive care admission and 100% effective in preventing death, Araos said.

AstraZeneca's was 68.7% effective in preventing symptomatic COVID-19 in the same period, 98% effective in preventing intensive care admissions and 100% effective in preventing death, Araos said.


Chile's study examined the vaccines' effectiveness among different cohorts of people who either received two doses of the specified vaccine, partial doses of the vaccine or no vaccine at all.

The CoronaVac part of the study examined a group of 8.6 million people, the Pfizer BioNTech part studied a group of 4.5 million people and the AstraZeneca part looked at a group of 2.3 million people.
 
Last edited:
We already have another case study to gauge effectiveness of Chinese Vaccines - Indonesia. Chinese vaccines proved significantly useless against the raging Indian variant whereas western vaccines are doing surprisingly well against the same variant.

Unfortunately my folks back home got the Chinese ones. For now, I've told them to take precautions assuming they're not vaccinated. Alliance with China doesn't mean we stop calling black, black.
Many people died compared to how many are vaccinated ???? That is a huge success, Indonesia infection seems contained considering only a few million are vaccinated.
 
Lol. If you have the guts, tag and quote my post instead.



The ideal vaccine is still to prevent infections, not just deaths, so as to achieve herd immunity. Unfortunately, circumstances have changed for the worse. But even still, vaccines still have different efficacies and we're looking out for vaccines which can reduce mortality to the greatest extent even without preventing infection.

Because no current vaccine is effective in preventing delta infection, we have to fall back on looking at just mortality rates to determine which current vaccine can 'reduce mortality to the greatest extent'.

Also, delta is not the only variant around. Delta has not even hit Chile yet.

View attachment 767291



You're selectively picking data, and you know that. What about the months before that?

Chile may have seen daily deaths fall in the past month, but it has not seen any significant reduction in deaths since inoculation started in January.

View attachment 767288
View attachment 767289

On the other hand, the UK has seen a significant reduction in deaths since its peak in January, despite the current uptick.

View attachment 767286
View attachment 767287

Chile's own real world study shows that there are indeed differences in vaccine efficacies.



SANTIAGO, Aug 3 (Reuters) - Sinovac's COVID-19 vaccine was 58.5% effective in preventing symptomatic illness among millions of Chileans who received it between February and July, the Chilean health authorities said on Tuesday, while Pfizer's COVID-19 shot was 87.7% effective and AstraZeneca's was 68.7% effective.

The data came in the latest "real world" data published by the Chilean authorities into the effectiveness among its population of a raft of COVID-19 vaccines.

Chile began one of the world's fastest inoculation campaigns against COVID-19 in December, having now fully vaccinated more than 60% of its population, predominantly with Sinovac's (SVA.O)CoronaVac.

That vaccine was 86% effective in preventing hospitalization, 89.7% effective in preventing admission to intensive care units and 86% effective in preventing deaths within the population between February and July, health official Dr Rafael Araos said in a press conference on Tuesday.

In April, the same study found that CoronaVac was 67% effective in preventing symptomatic illness, 85% effective in preventing hospitalizations and 80% effective in preventing deaths, suggesting its capacity to prevent the more serious impacts of the virus has strengthened, while its capacity to stop symptomatic illness diminished.

Araos said a reduction in protection from vaccines was inevitable over time, particularly with the arrival and growing prevalence of more virulent strains such as the Delta variant.

"If Delta becomes more prevalent and the vaccine has a weaker response, we could observe a faster fall (in effectiveness)," he said, adding his voice to calls for a third, booster dose to be issued.

The government also published data on the effectiveness of other vaccines administered in Chile, made by Pfizer BioNTech (PFE.N), (22UAy.DE) and AstraZeneca (AZN.L).

Pfizer's vaccine was 87.7% effective in preventing symptomatic COVID-19 in the same period, 98% effective in preventing intensive care admission and 100% effective in preventing death, Araos said.

AstraZeneca's was 68.7% effective in preventing symptomatic COVID-19 in the same period, 98% effective in preventing intensive care admissions and 100% effective in preventing death, Araos said.


Chile's study examined the vaccines' effectiveness among different cohorts of people who either received two doses of the specified vaccine, partial doses of the vaccine or no vaccine at all.

The CoronaVac part of the study examined a group of 8.6 million people, the Pfizer BioNTech part studied a group of 4.5 million people and the AstraZeneca part looked at a group of 2.3 million people.
Need to note down, the Chile uses mostly Sinovac vaccine so it is going down curve:


1628129648855.png


While USA and Israel are mostly using mRNA Vaccines and we can see via the two charts that they are going up despite most of their population taking the vaccines.


1628129668602.png



1628129687803.png


This suggested that any western media news source will always be bias against Chinese Vaccines and you have no clue what you are talking about.
 
Need to note down, the Chile uses mostly Sinovac vaccine so it is going down curve:


View attachment 767475

While USA and Israel are mostly using mRNA Vaccines and we can see via the two charts that they are going up despite most of their population taking the vaccines.


View attachment 767476


View attachment 767477

This suggested that any western media news source will always be bias against Chinese Vaccines and you have no clue what you are talking about.

Read my posts again.

1) Delta has not even hit Chile yet.
1628139504482.png


2) Daily deaths in Chile today are no different than in January (even higher actually), while in the UK, US, Israel we have seen a significant fall in deaths.

1628139885739.png

1628139913593.png



3) Chile's own study concluded that Pfizer vaccine is more effective and AZ, and AZ is more effective than Sinovac.


SANTIAGO, Aug 3 (Reuters) - Sinovac's COVID-19 vaccine was 58.5% effective in preventing symptomatic illness among millions of Chileans who received it between February and July, the Chilean health authorities said on Tuesday, while Pfizer's COVID-19 shot was 87.7% effective and AstraZeneca's was 68.7% effective.

The data came in the latest "real world" data published by the Chilean authorities into the effectiveness among its population of a raft of COVID-19 vaccines.

Chile began one of the world's fastest inoculation campaigns against COVID-19 in December, having now fully vaccinated more than 60% of its population, predominantly with Sinovac's (SVA.O)CoronaVac.

That vaccine was 86% effective in preventing hospitalization, 89.7% effective in preventing admission to intensive care units and 86% effective in preventing deaths within the population between February and July, health official Dr Rafael Araos said in a press conference on Tuesday.

...

Pfizer's vaccine was 87.7% effective in preventing symptomatic COVID-19 in the same period, 98% effective in preventing intensive care admission and 100% effective in preventing death, Araos said.

AstraZeneca's was 68.7% effective in preventing symptomatic COVID-19 in the same period, 98% effective in preventing intensive care admissions and 100% effective in preventing death, Araos said.
 
Lol. If you have the guts, tag and quote my post instead.



The ideal vaccine is still to prevent infections, not just deaths, so as to achieve herd immunity. Unfortunately, circumstances have changed for the worse. But even still, vaccines still have different efficacies and we're looking out for vaccines which can reduce mortality to the greatest extent even without preventing infection.

Because no current vaccine is effective in preventing delta infection, we have to fall back on looking at just mortality rates to determine which current vaccine can 'reduce mortality to the greatest extent'.

Also, delta is not the only variant around. Delta has not even hit Chile yet.

View attachment 767291



You're selectively picking data, and you know that. What about the months before that?

Chile may have seen daily deaths fall in the past month, but it has not seen any significant reduction in deaths since inoculation started in January.

View attachment 767288
View attachment 767289

On the other hand, the UK has seen a significant reduction in deaths since its peak in January, despite the current uptick.

View attachment 767286
View attachment 767287

Chile's own real world study shows that there are indeed differences in vaccine efficacies.



SANTIAGO, Aug 3 (Reuters) - Sinovac's COVID-19 vaccine was 58.5% effective in preventing symptomatic illness among millions of Chileans who received it between February and July, the Chilean health authorities said on Tuesday, while Pfizer's COVID-19 shot was 87.7% effective and AstraZeneca's was 68.7% effective.

The data came in the latest "real world" data published by the Chilean authorities into the effectiveness among its population of a raft of COVID-19 vaccines.

Chile began one of the world's fastest inoculation campaigns against COVID-19 in December, having now fully vaccinated more than 60% of its population, predominantly with Sinovac's (SVA.O)CoronaVac.

That vaccine was 86% effective in preventing hospitalization, 89.7% effective in preventing admission to intensive care units and 86% effective in preventing deaths within the population between February and July, health official Dr Rafael Araos said in a press conference on Tuesday.

In April, the same study found that CoronaVac was 67% effective in preventing symptomatic illness, 85% effective in preventing hospitalizations and 80% effective in preventing deaths, suggesting its capacity to prevent the more serious impacts of the virus has strengthened, while its capacity to stop symptomatic illness diminished.

Araos said a reduction in protection from vaccines was inevitable over time, particularly with the arrival and growing prevalence of more virulent strains such as the Delta variant.

"If Delta becomes more prevalent and the vaccine has a weaker response, we could observe a faster fall (in effectiveness)," he said, adding his voice to calls for a third, booster dose to be issued.

The government also published data on the effectiveness of other vaccines administered in Chile, made by Pfizer BioNTech (PFE.N), (22UAy.DE) and AstraZeneca (AZN.L).

Pfizer's vaccine was 87.7% effective in preventing symptomatic COVID-19 in the same period, 98% effective in preventing intensive care admission and 100% effective in preventing death, Araos said.

AstraZeneca's was 68.7% effective in preventing symptomatic COVID-19 in the same period, 98% effective in preventing intensive care admissions and 100% effective in preventing death, Araos said.


Chile's study examined the vaccines' effectiveness among different cohorts of people who either received two doses of the specified vaccine, partial doses of the vaccine or no vaccine at all.

The CoronaVac part of the study examined a group of 8.6 million people, the Pfizer BioNTech part studied a group of 4.5 million people and the AstraZeneca part looked at a group of 2.3 million people.
It's winter in chile now,you don't know that? What a genius show so many graphs but don't have a brain to process it..
 
any western media news source will always be bias against Chinese Vaccines and you have no clue what you are talking about.


1628141342840.png

It's winter in chile now,you don't know that? What a genius show so many graphs but don't have a brain to process it..

So how about rebutting my points fully, instead of glossing it over with "winter in Chile now, you have no brain"? You can show me other studies which indicate that Sinovac is more effective than mRNA and I will concede.

1628140820593.png


8/184 = 4.3%

1628140981865.png
 
Last edited:
And I stand by my claim that mRNA vaccines are still more effective than Sinovac. I still see no convincing counterargument.

Comparing mRNA with inactivated is sort of like comparing long bow with crossbow. Both have advantages and disadvantages.
And I stand by my claim that mRNA vaccines are still more effective than Sinovac. I still see no convincing counterargument.

China has mRNA vaccines too. Walvax makes 2nd generation ones which don't even need refrigeration.
 
Last edited:
If you want to tag me, tag me from the start instead of editing. I didn't receive your notification.

And I stand by my claim that mRNA vaccines are still more effective than Sinovac. I still see no convincing counterargument.




View attachment 767080

I don't see a drop in daily deaths in Chile since its vaccination started since around January.

OTOH deaths in Israel, UK and the US have dropped significantly since vaccination around January, despite more getting recently infected with delta.

View attachment 767081
View attachment 767082
View attachment 767083


Lmao. Yeah yeah, typical of Chinese keyboard warriors to say that.

This tells the story: Deaths since after vaccines were widely available...
Screen Shot 2021-10-10 at 8.27.40 PM.jpg

Even though the majority of the US lives in California and the Northeast the deathrate is NOWHERE near the South where vaccination rates are the lowest (ie full of stubborn dummies).

The vaccines work...case closed.
..and remember the virus supposedly likes northern colder climates.


Screen Shot 2021-10-10 at 8.42.24 PM.jpg
 
Last edited:
Back
Top Bottom